Answers are grounded in this paper and cite their sources.
Ferroptosis has become a promising target for cancer treatment since its discovery. However, tumor cells reinforce the defense systems to strengthen ferroptosis resistance. Here, we reported a positive feedback loop containing the serine and arginine rich splicing factor 6 (SRSF6) and fat mass and obesity-associated protein (FTO), which played crucial roles in the enhancement of cellular ferroptosis resistance and tumor progression in head and neck squamous cell carcinoma. Mechanistically, the SRSF6/FTO loop activated the sterol regulatory element binding transcription factors signaling pathway through FTO-mediated m6A demethylation, especially the upregulation of stearoyl-CoA desaturase, a key defender against ferroptosis. These findings provided new insights and directions for understanding the ferroptosis resistance of tumor cells.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: